Gene Expression Profiling of Mediators Associated with the Inflammatory Pathways in the Intestinal Tissue from Patients with Ulcerative Colitis

Table 2

Clinical and demographic characteristics of ulcerative colitis patients and controls.

Patients number, gender (F/M)	(52/48)
Age (years range)	(20-75)
Disease duration (1-3/>3 years)	(39/61)
Disease activity (active/remission)	(50/50)
Disease extension (Montreal classification)
E1-proctitis/E2-left-sided colitis/E3-pancolitis	(35/9/56)
Endoscopic activity (inactive/mild/moderate/severe)	(50/26/12/12)
Histological activity (inactive/mild/moderate/severe)	(50/24/14/12)
Current therapy: 5-aminosalicylate/corticosteroids	(69/31)
Extraintestinal manifestations (without/arthritis/others)	(60/24/16)
Control group
Number of patients, sex (F/M)	(21/39)
Age (year range)	(19-70)
Treatment (5-aminosalicylate/corticosteroids)	(0/0)